Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the limited partnership opportunities available for the 2023 event, please get in touch at email@example.com
The next-generation conjugate space is growing at an exponential rate. With ~200 preclinically active assets, and ~100 clinically active, the market opportunity for providers of services that are being utilized by drug developers from discovery through to manufacturing is also growing.
The 2nd Next-Generation Conjugates Summit united 120+ leaders pioneering the development of conjugates with novel payloads including oligonucleotides, degraders, immunostimulatory agents, through to novel formats including antibody fragments, bispecifics and targeted nanoparticles, thus offering you the opportunity to showcase your scientific expertise and thought-leadership directly to a room full of your potential customers.
Whether you need to communicate exciting progress to the decision-makers in the field, are looking to enhance or generate leads, or would like to get a grasp of next-generation investments in this market, you can rely on our ability to advise on and deliver the right solution for you.
Our Partnership Options include:
- Speaking engagements with the entire audience
- Hosting a Panel Discussion
- An Exhibition booth
- Pre-event and onsite Branding
- Hosting a sponsored drinks reception or lunch
As the market for next-generation conjugates continues to grow, this is the only event specifically designed to help progress conjugates with novel payloads and formats to improve translation and see clinical proof-of-concept.
There is no better opportunity this year to foster relationships and generate new business leads in this novel space.
Get in touch today!